Unlocking Patient Access: Harnessing Data for Pharmaceutical Success in a Complex Market May 19, 2025
BioMarin to Acquire Inozyme Pharma for $270 Million, Targeting Life-Threatening Rare Diseases with Innovative Therapy INZ-701 May 19, 2025
BioMarin Seals $270 Million Deal to Expand Rare Disease Portfolio with Inozyme Pharma Acquisition May 19, 2025
BioMarin Strengthens Rare Disease Portfolio with $270 Million Acquisition of Inozyme Pharma May 18, 2025
BioMarin Pharmaceuticals Bets Big on Rare Diseases with $270 Million Inozyme Acquisition May 18, 2025
BioMarin Strengthens Rare Disease Portfolio with $270 Million Acquisition of Inozyme Pharma May 18, 2025
BioMarin Pharmaceutical Expands Rare Disease Portfolio with Strategic $270 Million Acquisition of Inozyme Pharma May 18, 2025
BioMarin Pharmaceutical to Acquire Inozyme Pharma for $270 Million, Targeting Rare Genetic Disorders with Promising New Therapy May 17, 2025
